World of Bacteria header image

Staphylococcus borealis

A recently described coagulase-negative staphylococcal species closely related to Staphylococcus haemolyticus, occasionally recovered from human clinical material and capable of producing yellow pigment and visible haemolysis on blood agar.

Basic Characteristics

Taxonomy

  • Domain: Bacteria
  • Phylum: Bacillota
  • Class: Bacilli
  • Order: Bacillales
  • Family: Staphylococcaceae
  • Genus: Staphylococcus
  • Species: Staphylococcus borealis

Microscopy & Gram Stain

  • Gram-positive cocci
  • Cells occur mainly in clusters, but pairs and short chains may also be present
  • Gram-stained preparations show the typical irregular staphylococcal arrangement

Oxygen Relationship

  • Facultatively anaerobic
  • Grows under routine aerobic culture conditions on blood agar

Rapid Identification Tests

  • Catalase: positive
  • Coagulase: negative
  • Oxidase: negative
  • Urease: reported as positive in the original species description

Ecology and Clinical Relevance

Natural Habitat

  • Human skin-associated microbiota
  • Occasional opportunistic human isolate
  • Originally described from human skin and blood isolates

Common Clinical Specimens

  • Skin-associated clinical material
  • Blood culture isolates
  • Urogenital specimens such as urethral swabs

Clinical Significance

  • Recently described coagulase-negative staphylococcus
  • Probably underrecognized rather than truly absent from routine clinical practice
  • May be confused with Staphylococcus haemolyticus and other haemolytic staphylococci

Differential Considerations

  • Staphylococcus haemolyticus is the most important differential species
  • Staphylococcus aureus may be considered because of yellow pigment and haemolysis
  • Other pigmented or haemolytic coagulase-negative staphylococci

Diagnostic and Clinical Notes

This isolate is visually instructive because it combines two features that strongly influence first impressions on blood agar: yellow pigmentation and beta-haemolysis.

In this page set, the haemolytic effect was already visible after 24 hours and became more pronounced after prolonged incubation, which increases the risk of overcalling the isolate as a more familiar haemolytic staphylococcal species.

Staphylococcus borealis is still a relatively unfamiliar name in routine clinical microbiology and may therefore remain hidden among isolates reported more broadly as S. haemolyticus or as haemolytic coagulase-negative staphylococci.

In your material, the strain originated from a urethral swab from a 47-year-old man together with significant growth of Enterococcus faecalis, which illustrates that clinical interpretation should always consider specimen context and accompanying flora.

Because the species is recently described, its overall clinical significance is still being clarified. Current practical value lies mainly in recognizing that unusual yellow-pigmented and haemolytic coagulase-negative staphylococci may represent taxa that are not yet widely familiar in routine diagnostics.

Laboratory Identification

Colony Morphology

On blood agar, this isolate formed smooth, convex colonies with entire margins. Yellow pigment was present and became more intense with prolonged incubation, while beta-haemolysis around the colonies became clearer after 48 hours.

Microscopy

The Gram-stained colony smear shows Gram-positive cocci occurring singly, in pairs, short chains, and especially in clusters of variable size and shape. This appearance is fully compatible with the genus Staphylococcus but does not by itself secure species identification.

Key Identification Clues

  • Gram-positive cocci in clusters
  • Catalase positive and coagulase negative
  • Yellow pigment visible on blood agar
  • Beta-haemolysis that becomes more obvious with incubation time
  • Potential confusion with Staphylococcus haemolyticus and haemolytic S. aureus

Modern Identification Methods

Reliable identification is best achieved with MALDI-TOF MS only if the reference database is up to date; otherwise, sequencing or genome-based methods may be needed for difficult isolates. This is especially relevant for Staphylococcus borealis because the species was only formally described recently and may still be underrepresented in older identification systems.

Antibiotic Characteristics

No simple species-level susceptibility rule should be assumed for Staphylococcus borealis. Because it is newly described and still being clinically characterized, antimicrobial susceptibility testing should be performed on the individual isolate rather than inferred from appearance or from a preliminary resemblance to other coagulase-negative staphylococci.

In practical laboratory work, resemblance to Staphylococcus haemolyticus should not be taken to imply identical resistance behaviour. Even when a newly recognized species is phenotypically similar to a familiar taxon, susceptibility interpretation must remain isolate-specific.

Note: Treatment decisions should always be guided by laboratory susceptibility testing and clinical context.

External Resources

For broader general information about Staphylococcus borealis, external resources can be added here later if needed.